Expertise in
8
conditions

Dr. Nathaniel S. Winstead

Gastroenterology
Eastern Shore Ear Nose & Throat Clinic PC
188 Hospital Dr Ste 405, 
Fairhope, AL 
Accepting New Patients
Expertise in
8
conditions
Eastern Shore Ear Nose & Throat Clinic PC
188 Hospital Dr Ste 405, 
Fairhope, AL 

Overview

Nathaniel Winstead is a Gastroenterologist practicing medicine in Fairhope, Alabama.

Dr. Winstead is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Diverticular Disease, Crohn's Disease, Painful Swallowing, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 9 clinical trials. Dr. Winstead is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in LA

Hospital Affiliations

Mobile Infirmary Medical Center
Thomas Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Eastern Shore Ear Nose & Throat Clinic PC
188 Hospital Dr Ste 405, Fairhope, AL 36532

Additional Areas of Focus

Dr. Winstead has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

2 Total Publications

Medical management of constipation.
Medical management of constipation.
Journal: Clinics in colon and rectal surgery
Published: March 02, 2013
Similar Doctors
Expertise in
27
conditions
Dr. Matthew M. Eves
Gastroenterology
Expertise in
27
conditions
Dr. Matthew M. Eves
Gastroenterology
Referral may be required

Eastern Shore Ear Nose & Throat Clinic PC

188 Hospital Dr Ste 405, 
Fairhope, AL 
 (0.1 miles away)
251-990-0360
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Eves is a Gastroenterologist practicing medicine in Fairhope, Alabama. Dr. Eves is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Choledocholithiasis, Acute Pancreatitis, Familial Pancreatic Cancer, Endoscopy, and Colonoscopy. Dr. Eves is currently accepting new patients.

Expertise in
29
conditions
Dr. Amy R. Woods
Gastroenterology
Expertise in
29
conditions
Dr. Amy R. Woods
Gastroenterology
Referral may be required

Baldwin Health Gastroenterology

1518 N McKenzie St Ste 400, 
Foley, AL 
 (11.3 miles away)
251-949-3842
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amy Woods is a Gastroenterologist practicing medicine in Foley, Alabama. Dr. Woods is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Barrett Esophagus, Chronic Erosive Gastritis, Painful Swallowing, Colonoscopy, and Gastrectomy. Dr. Woods is currently accepting new patients.

Expertise in
56
conditions
Dr. Samer H. Al-Shurieki
Gastroenterology
Expertise in
56
conditions
Dr. Samer H. Al-Shurieki
Gastroenterology
Referral may be required

Gastroenterology Center At Medical Center Clinic - Building 1, Floor 2

8333 N Davis Hwy, 
Pensacola, FL 
 (38.3 miles away)
850-474-8428
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Samer Al-Shurieki is a Gastroenterologist practicing medicine in Pensacola, Florida. Dr. Al-Shurieki is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Lower Esophageal Ring, Benign Esophageal Stricture, Painful Swallowing, Gastrectomy, and Colonoscopy. Dr. Al-Shurieki is currently accepting new patients.

Frequently Asked Questions about Dr. Nathaniel S. Winstead

How do I make an appointment with Dr. Nathaniel S. Winstead?

You can book an appointment with Dr. Nathaniel S. Winstead by calling their office at 251-990-0360. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nathaniel S. Winstead a top-rated expert for Diverticular Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nathaniel S. Winstead is classified as an Advanced expert for Diverticular Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nathaniel S. Winstead specialize in?

While Dr. Nathaniel S. Winstead is a Gastroenterology, they have specific expertise in Diverticular Disease, Crohn's Disease, and Painful Swallowing. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Nathaniel S. Winstead participate in research or clinical trials?

Yes. Dr. Nathaniel S. Winstead has published 2 articles and abstracts on conditions like Diverticular Disease. You can view a list of Dr. Nathaniel S. Winstead's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nathaniel S. Winstead accept my insurance?

Dr. Nathaniel S. Winstead accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 251-990-0360 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Winstead's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 60 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile